EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment

Shuaiwen Hu, Biquan Li, Meng Su, Qisong Liu, Yujie Liang, Jiang Xia, Xiaohua Pan

International Journal of Pharmaceutics: X · 2026-11 · 100709

DOI: 10.1016/j.ijpx.2026.100709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutics: X, 2026-11. Verfasst von Shuaiwen Hu und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hu, S., Li, B., Su, M., Liu, Q., Liang, Y., Xia, J., & Pan, X. (2026). Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment. International Journal of Pharmaceutics: X, 100709. https://doi.org/10.1016/j.ijpx.2026.100709

Vancouver

Hu S, Li B, Su M, Liu Q, Liang Y, Xia J, et al. Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment. International Journal of Pharmaceutics: X. 2026:100709. doi:10.1016/j.ijpx.2026.100709

BibTeX
@article{Hu2026,
  author = {Hu, Shuaiwen and Li, Biquan and Su, Meng and Liu, Qisong and Liang, Yujie and Xia, Jiang and Pan, Xiaohua},
  title = {Erythrocyte-derived extracellular vesicles for bone-targeting delivery of Cas9 ribonucleoprotein complex and osteoporosis treatment},
  journal = {International Journal of Pharmaceutics: X},
  year = {2026},
  pages = {100709},
  doi = {10.1016/j.ijpx.2026.100709}
}
Kostenlos starten →